2024-08-012025-04-21https://scholars.lib.ntu.edu.tw/handle/123456789/728370eCD16A/anti-CD3-BFP雙功能性抗體可轉化內源性抗體成為可毒殺癌細胞之治療性抗體，引導T細胞至腫瘤處毒殺癌細胞。此研究除可拓展癌症免疫治療之策略，並可有未來臨床及商業發展潛力，造福更多病患。雙功能性抗體內生性抗體癌症免疫治療EB病毒bifunctional antibodyendogenous antibodycancer immunotherapyEB virusTransforming Endogenous Cancer-Targeting Antibodies into T Cell Redirecting Bifunctional Antibodies with Ecd16a/Anti-Cd3-Bfp: Proof-Of-Concept Explorations of a Novel Immunotherapy Strategy